Further to the announcement made on 13 September 2018, Scapa Group plc (AIM: SCPA) is pleased to announce that its acquisition of the share capital of Systagenix Wound Management Manufacturing Limited completed on 1 October 2018. In addition, Scapa and Acelity have now entered into the exclusive five-year manufacturing and supply agreement for Systagenix advanced wound care products that are currently manufactured in the Gargrave facility, with immediate effect.
Back to All News
All Market News
Other Market News
GSK plc Receives Approval for Shingrix Vaccine in Japan
MP Evans plc- Acquisition of Further Hectarage
Harworth Group plc Publication of Response Document to the Offer by Peel Pepper (UK) Limited
Harworth Group plc Results for Six Months Ended June 2026
Murray Income Trust plc Annual Report and Accounts Year Ended June 2026
Henderson High Income Trust plc- Unaudited Reulsts to June 2026
Sign up for our Stock News Highlights
Delivered to your inbox every Friday